Table 1.
Key characteristics of subjects
| Control groups n=86 | Disease groups n=236 | t/χ2 | P | |
|---|---|---|---|---|
| Age, years | 62.1±10.2 | 59.8±9.5 | 1.884 | 0.060 |
| Male, (%) | 67 (77.9) | 198 (83.9) | 1.553 | 0.213 |
| Smoker, (%) | 34 (39.5) | 82 (34.7) | 0.627 | 0.428 |
| SBP mm Hg | 128±20 | 132±22 | 1.478 | 0.140 |
| DBF, mm Hg | 76±8 | 74±9 | 1.816 | 0.070 |
| BMI, kg/m2 | 24.6±4.1 | 23.7±3.5 | 1.948 | 0.052 |
| LVEF, (%) | 58.1±8.1 | 56.4±7.6 | 1.136 | 0.455 |
| Total cholesterol, mg/dL | 166.3±21.1 | 171.6±23.5 | 1.839 | 0.067 |
| HDL, mg/dL | 54.5±15.0 | 52.9±16.3 | 0.796 | 0.427 |
| LDL, mg/dL | 95.6±28.8 | 92.5±28.2 | 0.868 | 0.386 |
| Triglycerides, mg/dL | 76.8±34.2 | 70.7±35.5 | 1.377 | 0.169 |
| ACE inhibitors (%) | 51 (59.3) | 122 (53) | 1.467 | 0.226 |
| ARBs (%) | 9 (10.4) | 24 (10) | 0.006 | 0.938 |
| Statins (%) | 61 (70.9) | 190 (80) | 3.364 | 0.067 |
ACE - angiotensin converting enzyme; ARB - angiotensin II receptor blockers; BMI - body mass index; DBP - diastolic blood pressure; HDL - high density lipoprotein; LDL - low density lipoprotein; LVEF - left ventricular ejection fraction; SBP - systolic blood pressure